RIYADH: The Saudi Food and Drug Authority imposed penalties on 54 facilities found to be in violation of the Pharmaceutical and Herbal Establishments and Substances Law.
The violations include failing to provide their registered pharmaceutical products to the local market, to directly report the movement of drugs through the electronic tracking system, and to notify authorities about an expected shortage or interruption in providing their registered products to the market in March.
Inspectors detected 22 facilities that did not commit to providing their registered pharmaceutical products to the market, 21 facilities that failed to directly report the movement of drugs through the electronic tracking system, and 11 facilities that did not report an expected shortage or interruption in providing their registered products to the market in March. Penalties were imposed on the facilities.
According to the law, it is mandatory for factories and warehouses to have stocks of all their registered products sufficient for six months. It is also mandatory for those facilities to report ahead of time to the authority if they expect a shortage of those registered products or an interruption in supplying them to the market for a period of six months while providing solutions to make up for the shortage.
